Trial
NCT00162773
Effect of Anti-IgE in Non-Allergic Asthma
Phase IITERMINATEDOPERATIONALConfidence: HIGH
Sponsor
Johns Hopkins University
Collaborators
Genentech, Inc.
Condition
Asthma
Intervention
omalizumab
Why stopped
PI left institution
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2017-08-28